These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28008855)

  • 1. Re: Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, et al. Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. Eur Urol 2017;71:195-201.
    Brookman-May SD; May M; Lebentrau S; Klotz T
    Eur Urol; 2017 May; 71(5):e145-e146. PubMed ID: 28008855
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Michael J. Morris, Daisy Huang, William K. Kelly, et al. Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate. Eur Urol 2009;56:237-44.
    Drewa T; Chlosta P
    Eur Urol; 2010 Feb; 57(2):e18-9; author reply e20. PubMed ID: 19853990
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Phillip J. Gray, Chun Chieh Lin, Matthew R. Cooperberg, Ahmedin Jemal, Jason A. Efstathiou. Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate Cancer. Eur Urol 2017;71:729-37.
    Gild P; von Landenberg N; Cole AP
    Eur Urol; 2017 Jun; 71(6):e181-e182. PubMed ID: 28040352
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Urs E. Studer, Laurence Collette, Peter Whelan, et al. Using PSA to guide timing of androgen deprivation in patients with T0-4 N0-2 M0 prostate cancer not suitable for local curative treatment (EORTC 30891). Eur Urol 2008;53:941-9 and re: John Anderson. Androgen-deprivation therapy--It's all a matter of timing. Eur Urol 2008;53:869-71.
    Kirollos MM
    Eur Urol; 2009 Feb; 55(2):e40-2; author reply e45-6. PubMed ID: 18760526
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7. Re: Ronald C. Chen. Postprostatectomy Radiotherapy: Whether and How Long to Give Concurrent Androgen Deprivation Therapy. Eur Urol 2016;69:58-9: Which patients need treatment intensification?
    Dal Pra A; Spahn M
    Eur Urol; 2016 Apr; 69(4):e74-e75. PubMed ID: 26508311
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
    Stephan C; Cammann H; Jung K
    Eur Urol; 2015 Nov; 68(5):e106-7. PubMed ID: 26215600
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Temiz MZ; Besiroglu H
    Eur Urol; 2018 May; 73(5):e130. PubMed ID: 29397220
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Dal Pra A; Supiot S; Ghadjar P
    Eur Urol; 2018 Feb; 73(2):e34-e35. PubMed ID: 28890243
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Philip Cornford, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer. Eur Urol 2021;79:263-82.
    von Eyben FE
    Eur Urol; 2021 Jun; 79(6):e176. PubMed ID: 33712301
    [No Abstract]   [Full Text] [Related]  

  • 10. Reply to Mustafa Z. Temiz and Huseyin Besiroglu's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 May; 73(5):e131-e132. PubMed ID: 29395499
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Carsten Stephan, Henning Cammann, and Klaus Jung's Letter to the Editor re: Scott A. Tomlins, John R. Day, Robert J. Lonigro, et al. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2015.04.039.
    Tomlins SA; Groskopf J; Chinnaiyan AM
    Eur Urol; 2015 Nov; 68(5):e108. PubMed ID: 26242717
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Alan Dal Pra, Stephane Supiot and Pirus Ghadjar's Letter to the Editor re: Giorgio Gandaglia, Stephen A. Boorjian, William P. Parker, et al. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis. Eur Urol 2017;72:910-7.
    Gandaglia G; Fossati N; Montorsi F; Briganti A
    Eur Urol; 2018 Feb; 73(2):e36-e37. PubMed ID: 28890246
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: William C. Jackson, Matthew J. Schipper, Skyler B. Johnson, et al. Duration of Androgen Deprivation Therapy Influences Outcomes for Patients Receiving Radiation Therapy Following Radical Prostatectomy. Eur Urol 2016;69:50-7.
    Hu YW
    Eur Urol; 2016 Dec; 70(6):e158. PubMed ID: 27166669
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Obesity and prostate cancer: importance of race and stage of disease. S. J. Freedland. J Urol 2007; 178: 1842-1843.
    Bennett JK; Foote J; Alphonse P; Hood N
    J Urol; 2008 Jun; 179(6):2481-2; author reply 2482. PubMed ID: 18436256
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: Graefen M, Augustin H, Karakiewicz PI, Hammerer PG, Haese A, Palisaar J, et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. Eur Urol 2003;43(1):6-11.
    Borque A
    Eur Urol; 2003 Sep; 44(3):377. PubMed ID: 12932940
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Sung Kim, Shunhua Shen, Dirk F. Moore, et al. Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol 2011;60:908-16.
    Rossi CJ
    Eur Urol; 2012 May; 61(5):e43; author reply e44. PubMed ID: 22326675
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: M. Minhaj Siddiqui, Soroush Rais-Bahrami, Hong Truong, et al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013;64:713-9 and Re: Mark Emberton. Has magnetic resonance-guided biopsy of the prostate become the standard of care? Eur Urol 2013;64:720-1.
    van den Bergh RC; van der Poel HG
    Eur Urol; 2014 Jun; 65(6):e106-7. PubMed ID: 24411989
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Jennifer R. Rider, Kathryn M. Wilson, Jennifer A. Sinnott, Rachel S. Kelly, Lorelei A. Muccia, Edward L. Giovannucci. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. Eur Urol 2016;70:974-82.
    Annweiler C; Bigot P; Karras SN
    Eur Urol; 2017 Jan; 71(1):e16-e17. PubMed ID: 27267886
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Daher C. Chade, Shahrokh F. Shariat, Angel M. Cronin, et al. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration. Eur urol 2011;60:205-10.
    Qin X; Ye D
    Eur Urol; 2011 Oct; 60(4):e34. PubMed ID: 21764210
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: David W. Donnelly, Anna Gavin, Amy Downing, et al. Regional Variations in Quality of Survival Among Men with Prostate Cancer Across the United Kingdom. Eur Urol 2019;76:228-37.
    Clarke N; Payne H; van der Meulen J
    Eur Urol; 2020 Mar; 77(3):e65. PubMed ID: 31213325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.